We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+14.91%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$141B
AUM Growth
+$12.9B
Cap. Flow
-$2.58B
Cap. Flow %
-1.83%
Top 10 Hldgs %
23.5%
Holding
2,555
New
125
Increased
501
Reduced
893
Closed
65

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$46.9M
2
NET icon
Cloudflare
NET
+$38.2M
3
TXG icon
10x Genomics
TXG
+$33.7M
4
TDOC icon
Teladoc Health
TDOC
+$31.9M
5
PDD icon
Pinduoduo
PDD
+$31.4M

Sector Composition

Rank Sector Weight
1 Technology 26.42%
2 Healthcare 14.37%
3 Consumer Discretionary 13.81%
4 Communication Services 10.64%
5 Industrials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNTA
2551
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
-253,400
Closed -$13.3M
ARCH
2552
DELISTED
Arch Resources, Inc.
ARCH
-32,300
Closed -$1.37M
MOBL
2553
DELISTED
MobileIron, Inc.
MOBL
-196,100
Closed -$1.38M
PDLI
2554
DELISTED
PDL BioPharma, Inc.
PDLI
-250,900
Closed -$790K
AAN.A
2555
DELISTED
The Aaron's Company Inc Class A
AAN.A
-153,100
Closed -$8.67M

Similar funds

Swiss National Bank's Q4 2020 Portfolio in Review

As of Q4 2020, Swiss National Bank held 2,555 positions worth $141B, up 10% from $128B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Swiss National Bank's Q4 2020 filing shows 125 new, 501 increased, 893 reduced and 65 closed positions. Its largest new stake was Cloudflare: 582,300 shares worth $44.2M. The largest sale was Apple, an estimated $349M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Swiss National Bank's largest Q4 2020 buy was Cloudflare: 582,300 shares worth $44.2M.
  • Swiss National Bank added most to Viatris in Q4 2020, an estimated $46.9M increase.
  • Swiss National Bank's biggest Q4 2020 reduction was Apple, cutting an estimated $349M.
  • Swiss National Bank fully exited Immunomedics Inc in Q4 2020, selling an estimated $37.8M.
  • Swiss National Bank's ten largest holdings make up 24% of its $141B portfolio in Q4 2020.
  • Swiss National Bank opened 125 new positions and closed 65 in Q4 2020.
  • Swiss National Bank's portfolio value rose 10% quarter-over-quarter to $141B.

Based on Swiss National Bank's 13F filing for Q4 2020, filed 5 Feb 2021.